Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy
Clinical trial NCT03193463 · WITHDRAWN
Trial details
- NCT number
- NCT03193463
- Sponsor
- Michael Vogelbaum, MD, PhD
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2018-11-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.